Report Detail

Request for Sample of this report

Pharma & Healthcare Global Bacille Calmette-Guerin Vaccine Supply, Demand and Key Producers, 2026-2032

  • RnM4665926
    • |
  • 19 January, 2026
    • |
  • Global
    • |
  • 118 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

The global Bacille Calmette-Guerin Vaccine market size is expected to reach $ 104 million by 2032, rising at a market growth of 3.0% CAGR during the forecast period (2026-2032).
The Bacille Calmette-Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). Developed from a strain of weakened Mycobacterium bovis, the BCG vaccine is commonly administered to infants and children in countries where tuberculosis is prevalent. While it does not provide complete immunity, it significantly reduces the risk of severe forms of TB, such as TB meningitis and miliary tuberculosis in young children. BCG is also being researched for potential applications in treating bladder cancer and boosting immune responses in certain conditions.
The primary drivers of the Bacille Calmette-Guérin (BCG) vaccine market is the continued high prevalence of tuberculosis (TB) in many parts of the world, particularly in Asia and Africa. Increased awareness and government initiatives to control and eradicate TB contribute to demand for the vaccine. Additionally, ongoing research on the potential use of the BCG vaccine in treating other diseases, such as bladder cancer and potentially as a non-specific immune booster, is also bolstering its market demand.
A major challenge in the BCG vaccine market is supply constraints due to the limited number of manufacturers, as production requires specialized facilities and quality control measures. Additionally, the vaccine's effectiveness varies by region and is less protective in adults than in children, which affects its perception and demand in some areas. Furthermore, stringent regulatory standards and the relatively long time required for production can limit supply, especially during times of increased demand or global health crises. Asia-Pacific is the largest consumption place, with a consumption market share nearly 46% in 2023. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 36%. Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, etc. are the leaders of the industry.
This report studies the global Bacille Calmette-Guerin Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Bacille Calmette-Guerin Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Bacille Calmette-Guerin Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Bacille Calmette-Guerin Vaccine total production and demand, 2021-2032, (K Dose)
Global Bacille Calmette-Guerin Vaccine total production value, 2021-2032, (USD Million)
Global Bacille Calmette-Guerin Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Bacille Calmette-Guerin Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Bacille Calmette-Guerin Vaccine domestic production, consumption, key domestic manufacturers and share
Global Bacille Calmette-Guerin Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Bacille Calmette-Guerin Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Bacille Calmette-Guerin Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Bacille Calmette-Guerin Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Bacille Calmette-Guerin Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Bacille Calmette-Guerin Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Bacille Calmette-Guerin Vaccine Market, Segmentation by Type:
Immune Vaccine
Therapy Vaccine
Global Bacille Calmette-Guerin Vaccine Market, Segmentation by Application:
Self-Procurement
UNICEF
Other
Companies Profiled:
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC – Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Key Questions Answered:
1. How big is the global Bacille Calmette-Guerin Vaccine market?
2. What is the demand of the global Bacille Calmette-Guerin Vaccine market?
3. What is the year over year growth of the global Bacille Calmette-Guerin Vaccine market?
4. What is the production and production value of the global Bacille Calmette-Guerin Vaccine market?
5. Who are the key producers in the global Bacille Calmette-Guerin Vaccine market?
6. What are the growth factors driving the market demand?


1 Supply Summary

  • 1.1 Bacille Calmette-Guerin Vaccine Introduction
  • 1.2 World Bacille Calmette-Guerin Vaccine Supply & Forecast
    • 1.2.1 World Bacille Calmette-Guerin Vaccine Production Value (2021 & 2025 & 2032)
    • 1.2.2 World Bacille Calmette-Guerin Vaccine Production (2021-2032)
    • 1.2.3 World Bacille Calmette-Guerin Vaccine Pricing Trends (2021-2032)
  • 1.3 World Bacille Calmette-Guerin Vaccine Production by Region (Based on Production Site)
    • 1.3.1 World Bacille Calmette-Guerin Vaccine Production Value by Region (2021-2032)
    • 1.3.2 World Bacille Calmette-Guerin Vaccine Production by Region (2021-2032)
    • 1.3.3 World Bacille Calmette-Guerin Vaccine Average Price by Region (2021-2032)
    • 1.3.4 North America Bacille Calmette-Guerin Vaccine Production (2021-2032)
    • 1.3.5 Europe Bacille Calmette-Guerin Vaccine Production (2021-2032)
    • 1.3.6 China Bacille Calmette-Guerin Vaccine Production (2021-2032)
    • 1.3.7 Japan Bacille Calmette-Guerin Vaccine Production (2021-2032)
  • 1.4 Market Drivers, Restraints and Trends
    • 1.4.1 Bacille Calmette-Guerin Vaccine Market Drivers
    • 1.4.2 Factors Affecting Demand
    • 1.4.3 Bacille Calmette-Guerin Vaccine Major Market Trends

2 Demand Summary

  • 2.1 World Bacille Calmette-Guerin Vaccine Demand (2021-2032)
  • 2.2 World Bacille Calmette-Guerin Vaccine Consumption by Region
    • 2.2.1 World Bacille Calmette-Guerin Vaccine Consumption by Region (2021-2026)
    • 2.2.2 World Bacille Calmette-Guerin Vaccine Consumption Forecast by Region (2027-2032)
  • 2.3 United States Bacille Calmette-Guerin Vaccine Consumption (2021-2032)
  • 2.4 China Bacille Calmette-Guerin Vaccine Consumption (2021-2032)
  • 2.5 Europe Bacille Calmette-Guerin Vaccine Consumption (2021-2032)
  • 2.6 Japan Bacille Calmette-Guerin Vaccine Consumption (2021-2032)
  • 2.7 South Korea Bacille Calmette-Guerin Vaccine Consumption (2021-2032)
  • 2.8 ASEAN Bacille Calmette-Guerin Vaccine Consumption (2021-2032)
  • 2.9 India Bacille Calmette-Guerin Vaccine Consumption (2021-2032)

3 World Manufacturers Competitive Analysis

  • 3.1 World Bacille Calmette-Guerin Vaccine Production Value by Manufacturer (2021-2026)
  • 3.2 World Bacille Calmette-Guerin Vaccine Production by Manufacturer (2021-2026)
  • 3.3 World Bacille Calmette-Guerin Vaccine Average Price by Manufacturer (2021-2026)
  • 3.4 Bacille Calmette-Guerin Vaccine Company Evaluation Quadrant
  • 3.5 Industry Rank and Concentration Rate (CR)
    • 3.5.1 Global Bacille Calmette-Guerin Vaccine Industry Rank of Major Manufacturers
    • 3.5.2 Global Concentration Ratios (CR4) for Bacille Calmette-Guerin Vaccine in 2025
    • 3.5.3 Global Concentration Ratios (CR8) for Bacille Calmette-Guerin Vaccine in 2025
  • 3.6 Bacille Calmette-Guerin Vaccine Market: Overall Company Footprint Analysis
    • 3.6.1 Bacille Calmette-Guerin Vaccine Market: Region Footprint
    • 3.6.2 Bacille Calmette-Guerin Vaccine Market: Company Product Type Footprint
    • 3.6.3 Bacille Calmette-Guerin Vaccine Market: Company Product Application Footprint
  • 3.7 Competitive Environment
    • 3.7.1 Historical Structure of the Industry
    • 3.7.2 Barriers of Market Entry
    • 3.7.3 Factors of Competition
  • 3.8 New Entrant and Capacity Expansion Plans
  • 3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World

  • 4.1 United States VS China: Bacille Calmette-Guerin Vaccine Production Value Comparison
    • 4.1.1 United States VS China: Bacille Calmette-Guerin Vaccine Production Value Comparison (2021 & 2025 & 2032)
    • 4.1.2 United States VS China: Bacille Calmette-Guerin Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
  • 4.2 United States VS China: Bacille Calmette-Guerin Vaccine Production Comparison
    • 4.2.1 United States VS China: Bacille Calmette-Guerin Vaccine Production Comparison (2021 & 2025 & 2032)
    • 4.2.2 United States VS China: Bacille Calmette-Guerin Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
  • 4.3 United States VS China: Bacille Calmette-Guerin Vaccine Consumption Comparison
    • 4.3.1 United States VS China: Bacille Calmette-Guerin Vaccine Consumption Comparison (2021 & 2025 & 2032)
    • 4.3.2 United States VS China: Bacille Calmette-Guerin Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
  • 4.4 United States Based Bacille Calmette-Guerin Vaccine Manufacturers and Market Share, 2021-2026
    • 4.4.1 United States Based Bacille Calmette-Guerin Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    • 4.4.2 United States Based Manufacturers Bacille Calmette-Guerin Vaccine Production Value (2021-2026)
    • 4.4.3 United States Based Manufacturers Bacille Calmette-Guerin Vaccine Production (2021-2026)
  • 4.5 China Based Bacille Calmette-Guerin Vaccine Manufacturers and Market Share
    • 4.5.1 China Based Bacille Calmette-Guerin Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    • 4.5.2 China Based Manufacturers Bacille Calmette-Guerin Vaccine Production Value (2021-2026)
    • 4.5.3 China Based Manufacturers Bacille Calmette-Guerin Vaccine Production (2021-2026)
  • 4.6 Rest of World Based Bacille Calmette-Guerin Vaccine Manufacturers and Market Share, 2021-2026
    • 4.6.1 Rest of World Based Bacille Calmette-Guerin Vaccine Manufacturers, Headquarters and Production Site (State, Country)
    • 4.6.2 Rest of World Based Manufacturers Bacille Calmette-Guerin Vaccine Production Value (2021-2026)
    • 4.6.3 Rest of World Based Manufacturers Bacille Calmette-Guerin Vaccine Production (2021-2026)

5 Market Analysis by Type

  • 5.1 World Bacille Calmette-Guerin Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
  • 5.2 Segment Introduction by Type
    • 5.2.1 Immune Vaccine
    • 5.2.2 Therapy Vaccine
  • 5.3 Market Segment by Type
    • 5.3.1 World Bacille Calmette-Guerin Vaccine Production by Type (2021-2032)
    • 5.3.2 World Bacille Calmette-Guerin Vaccine Production Value by Type (2021-2032)
    • 5.3.3 World Bacille Calmette-Guerin Vaccine Average Price by Type (2021-2032)

6 Market Analysis by Application

  • 6.1 World Bacille Calmette-Guerin Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
  • 6.2 Segment Introduction by Application
    • 6.2.1 Self-Procurement
    • 6.2.2 UNICEF
    • 6.2.3 Other
  • 6.3 Market Segment by Application
    • 6.3.1 World Bacille Calmette-Guerin Vaccine Production by Application (2021-2032)
    • 6.3.2 World Bacille Calmette-Guerin Vaccine Production Value by Application (2021-2032)
    • 6.3.3 World Bacille Calmette-Guerin Vaccine Average Price by Application (2021-2032)

7 Company Profiles

  • 7.1 Merck
    • 7.1.1 Merck Details
    • 7.1.2 Merck Major Business
    • 7.1.3 Merck Bacille Calmette-Guerin Vaccine Product and Services
    • 7.1.4 Merck Bacille Calmette-Guerin Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.1.5 Merck Recent Developments/Updates
    • 7.1.6 Merck Competitive Strengths & Weaknesses
  • 7.2 Japan BCG Lab
    • 7.2.1 Japan BCG Lab Details
    • 7.2.2 Japan BCG Lab Major Business
    • 7.2.3 Japan BCG Lab Bacille Calmette-Guerin Vaccine Product and Services
    • 7.2.4 Japan BCG Lab Bacille Calmette-Guerin Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.2.5 Japan BCG Lab Recent Developments/Updates
    • 7.2.6 Japan BCG Lab Competitive Strengths & Weaknesses
  • 7.3 Serum Institute of India
    • 7.3.1 Serum Institute of India Details
    • 7.3.2 Serum Institute of India Major Business
    • 7.3.3 Serum Institute of India Bacille Calmette-Guerin Vaccine Product and Services
    • 7.3.4 Serum Institute of India Bacille Calmette-Guerin Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.3.5 Serum Institute of India Recent Developments/Updates
    • 7.3.6 Serum Institute of India Competitive Strengths & Weaknesses
  • 7.4 AJ Vaccines
    • 7.4.1 AJ Vaccines Details
    • 7.4.2 AJ Vaccines Major Business
    • 7.4.3 AJ Vaccines Bacille Calmette-Guerin Vaccine Product and Services
    • 7.4.4 AJ Vaccines Bacille Calmette-Guerin Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.4.5 AJ Vaccines Recent Developments/Updates
    • 7.4.6 AJ Vaccines Competitive Strengths & Weaknesses
  • 7.5 BioFarma
    • 7.5.1 BioFarma Details
    • 7.5.2 BioFarma Major Business
    • 7.5.3 BioFarma Bacille Calmette-Guerin Vaccine Product and Services
    • 7.5.4 BioFarma Bacille Calmette-Guerin Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.5.5 BioFarma Recent Developments/Updates
    • 7.5.6 BioFarma Competitive Strengths & Weaknesses
  • 7.6 GreenSignal Bio Pharma
    • 7.6.1 GreenSignal Bio Pharma Details
    • 7.6.2 GreenSignal Bio Pharma Major Business
    • 7.6.3 GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Product and Services
    • 7.6.4 GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.6.5 GreenSignal Bio Pharma Recent Developments/Updates
    • 7.6.6 GreenSignal Bio Pharma Competitive Strengths & Weaknesses
  • 7.7 China National Biotec
    • 7.7.1 China National Biotec Details
    • 7.7.2 China National Biotec Major Business
    • 7.7.3 China National Biotec Bacille Calmette-Guerin Vaccine Product and Services
    • 7.7.4 China National Biotec Bacille Calmette-Guerin Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.7.5 China National Biotec Recent Developments/Updates
    • 7.7.6 China National Biotec Competitive Strengths & Weaknesses
  • 7.8 Biomed Lublin
    • 7.8.1 Biomed Lublin Details
    • 7.8.2 Biomed Lublin Major Business
    • 7.8.3 Biomed Lublin Bacille Calmette-Guerin Vaccine Product and Services
    • 7.8.4 Biomed Lublin Bacille Calmette-Guerin Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.8.5 Biomed Lublin Recent Developments/Updates
    • 7.8.6 Biomed Lublin Competitive Strengths & Weaknesses
  • 7.9 Taj Pharmaceuticals
    • 7.9.1 Taj Pharmaceuticals Details
    • 7.9.2 Taj Pharmaceuticals Major Business
    • 7.9.3 Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Product and Services
    • 7.9.4 Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.9.5 Taj Pharmaceuticals Recent Developments/Updates
    • 7.9.6 Taj Pharmaceuticals Competitive Strengths & Weaknesses
  • 7.10 Ataulpho de Paiva
    • 7.10.1 Ataulpho de Paiva Details
    • 7.10.2 Ataulpho de Paiva Major Business
    • 7.10.3 Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Product and Services
    • 7.10.4 Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.10.5 Ataulpho de Paiva Recent Developments/Updates
    • 7.10.6 Ataulpho de Paiva Competitive Strengths & Weaknesses
  • 7.11 IVAC – Institute of Vaccines and Medical Biologicals
    • 7.11.1 IVAC – Institute of Vaccines and Medical Biologicals Details
    • 7.11.2 IVAC – Institute of Vaccines and Medical Biologicals Major Business
    • 7.11.3 IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Product and Services
    • 7.11.4 IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.11.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
    • 7.11.6 IVAC – Institute of Vaccines and Medical Biologicals Competitive Strengths & Weaknesses
  • 7.12 Queen Saovabha Mem. Inst
    • 7.12.1 Queen Saovabha Mem. Inst Details
    • 7.12.2 Queen Saovabha Mem. Inst Major Business
    • 7.12.3 Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Product and Services
    • 7.12.4 Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
    • 7.12.6 Queen Saovabha Mem. Inst Competitive Strengths & Weaknesses
  • 7.13 Microgen
    • 7.13.1 Microgen Details
    • 7.13.2 Microgen Major Business
    • 7.13.3 Microgen Bacille Calmette-Guerin Vaccine Product and Services
    • 7.13.4 Microgen Bacille Calmette-Guerin Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.13.5 Microgen Recent Developments/Updates
    • 7.13.6 Microgen Competitive Strengths & Weaknesses

8 Industry Chain Analysis

  • 8.1 Bacille Calmette-Guerin Vaccine Industry Chain
  • 8.2 Bacille Calmette-Guerin Vaccine Upstream Analysis
    • 8.2.1 Bacille Calmette-Guerin Vaccine Core Raw Materials
    • 8.2.2 Main Manufacturers of Bacille Calmette-Guerin Vaccine Core Raw Materials
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis
  • 8.5 Bacille Calmette-Guerin Vaccine Production Mode
  • 8.6 Bacille Calmette-Guerin Vaccine Procurement Model
  • 8.7 Bacille Calmette-Guerin Vaccine Industry Sales Model and Sales Channels
    • 8.7.1 Bacille Calmette-Guerin Vaccine Sales Model
    • 8.7.2 Bacille Calmette-Guerin Vaccine Typical Distributors

9 Research Findings and Conclusion

    10 Appendix

    • 10.1 Methodology
    • 10.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Bacille Calmette-Guerin Vaccine. Industry analysis & Market Report on Bacille Calmette-Guerin Vaccine is a syndicated market report, published as Global Bacille Calmette-Guerin Vaccine Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Bacille Calmette-Guerin Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,480.00
    		$6,720.00
    		$8,960.00
    		3,463.04
    		5,194.56
    		6,926.08
    		4,170.88
    		6,256.32
    		8,341.76
    		684,051.20
    		1,026,076.80
    		1,368,102.40
    		378,112.00
    		567,168.00
    		756,224.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo